Full-Time

Regulatory Policy

Standards and Product-related Environmental Protection Specialist

Posted on 10/13/2025

Varian

Varian

5,001-10,000 employees

Tech-enabled radiation oncology hardware and software

Compensation Overview

$128.5k - $192.7k/yr

Company Historically Provides H1B Sponsorship

Canada + 1 more

More locations: United States

In Person

Focus on North America (USA and Canada) for candidate location.

Category
Legal & Compliance (1)
Requirements
  • 10+ years of experience in policy/standards, product safety/compliance, quality assurance or regulatory affairs within a manufacturing industry. Prior work experience with FDA or industry associations is a plus.
  • Bachelor’s degree in engineering, life sciences, quality/EHS management, public health, health.
Responsibilities
  • Monitor federal, state/provincial and local product stewardship regulatory developments (i.e., chemicals and restricted substances in products and packaging, energy efficiency, product/packaging/battery recycling, etc.) via regulation monitoring tools/software and participation in national trade association and customer environmental working groups.
  • Monitor federal, provincial/state and local regulatory policy, standards and Product-related Environmental Protection (PEP) developments. These activities include: Proactively track, evaluate and communicate changes in regulatory policy, standards and PEP topics as relevant. Coordinate and communicate SHS participation in industry association activities (e.g. AdvaMed Imaging, AdvaMed, and MedTech Canada).
  • Advocate on behalf of SHS to minimize the impact of regulatory developments within NAM, with support of the global SHS PEP team, Legal and SHS NAM sales and service business.
  • Maintain current PEP/EHS obligations via SHS compliance registry tools.
  • Act as the process owner for PEP activity crafting and managing process documents; performing compliance gap assessments and improvements of internal processes which ensure compliance with existing PEP regulations concerning prohibitions, assembled product and/or component registration, labeling, marketing, sales reporting/fee payment and collection/recycling duties pursuant to extended producer responsibility (EPR).
  • Identify and communicate PEP risks to the global business entities and recommend corrective/preventive actions to NAM leadership and the global SHS PEP Team.
  • Maintain declarations from SHS factories and third-party suppliers that distribute products and ensure conformance to applicable environmental regulations.
  • Qualify and manage disassemblers, recyclers and disposal suppliers. Support customer take-back plans.
  • Liaise with environmental authorities and other stakeholders, including hosting audits and responding to PEP information requests raised in customer tenders.
  • Provide reports as needed and in a timely manner on regulatory policy, standards and PEP activities. This includes assistance in generating periodic internal reports as well as providing reports (synopsis, outcomes, action items) from meetings, federal, provincial/state and local developments, and all affiliated trade organization teleconferences. This further includes an internal weekly collaboration meeting, periodic newsletter, and maintenance of internal NAM regulatory policy, standards and PEP intranet site.
  • Coordinate SHS participation in industry association activities (e.g., AdvaMed Imaging, AdvaMed, and MedTech Canada) and in standards development organizations (e.g., AAMI). This includes representing SHS in such groups, ensuring SME participation when needed, and maintaining internal industry association rosters/SME distribution lists.
  • Establish and maintain relationships with internal parties (SMEs) and any affiliated regulatory policy, standards and PEP-related teams.
  • Complete and submit internal, federal, provincial/state and local PEP reports on behalf of SHS NAM as required (e.g., PFAS, EPR, Mercury).
  • Act as PEP Officer for NAM. Coordinate activities with the global SHS PEP team.
  • Coordinate activities with Latin America (LAM) region PEP Officers and the global SHS PEP team.
  • Additional responsibilities may be added as needed.
Desired Qualifications
  • PEP and EPR regulatory policies that identify manufacturers/importers/distributors as responsible parties for their products throughout their lifecycle, including after customers have used them.
  • ISO 14001 environmental management system requirements, including identification of relevant compliance obligations; ISO 13485 or 9001 a plus.
  • Distributor obligations related to product/material safety data sheets.
  • Federal, provincial, state and local PEP regulatory authorities and reporting requirements.
  • FDA/Health Canada oversight of the medical device industry, including sales and service.

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Simplify Jobs

Simplify's Take

What believers are saying

  • Telix collaboration integrates PET imaging with Ethos adaptive radiotherapy.
  • Halcyon installations expand into Saudi Arabia and Sri Lanka markets.
  • TrueBeam FDA clearance treats osteoarthritis for 33 million US patients.

What critics are saying

  • EU MDR Class III reclassification halts OaaS rollouts, cuts 25% renewals.
  • Eleksia cyclotrons capture 40% of Varian's $2B proton backlog by Q4 2026.
  • ViewRay APAC linacs undercut Halcyon with 30% faster treatments by mid-2026.

What makes Varian unique

  • Varian's ProBeam system powers New York Proton Center with $115M deal.
  • HyperSight imaging enhances Ethos, Halcyon, Edge, TrueBeam precision.
  • IntelliBlate microwave ablation creates controlled spherical zones for oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

401(k) Retirement Plan

Company News

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.

PR Newswire
Jul 29th, 2024
Varian Announces Future-Focused, Integrated Microwave Ablation Ecosystem With Intelliblate

PALO ALTO, Calif., July 29, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, announces receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IntelliBlate microwave ablation system, intended for ablation of soft tissue. Designed to provide clinicians with greater predictability, precision, and control during their procedures, IntelliBlate serves as the cornerstone of a future-focused, integrated ecosystem for microwave ablation.IntelliBlate produces large, controlled spherical ablation zones for predictable treatment delivery. With the option to utilize a single or dual probes – each with linked or independent controls – IntelliBlate delivers the versatility to meet the unique clinical needs of each patient. Precision and control are amplified by the Ximitry probe, which enables innovative features such as Laser Disk Alignment and intuitive LED indicators.The compact, versatile design and intuitive interface of IntelliBlate delivers a portable and flexible system that reduces barriers for this important treatment method. Modular elements provide the flexibility for clinicians to expand their treatment capabilities to meet changing clinical demands, all while keeping control over operational efficiency throughout the ablation procedure."IntelliBlate combines the features our customers say are most important for an efficient, integrated solution to seek improved levels of performance in microwave ablation," says Dr

PR Newswire
May 2nd, 2024
Together With Siemens Healthineers, Varian Showcases Commitment To Embracing Innovation And Enhancing Outcomes At Estro 2024

PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting, which will take place from May 3 to 7 in Glasgow, Scotland.With over 24 million new cancer cases expected by 2030, accessible, high-quality cancer treatment is crucial to improving patient outcomes1. Radiotherapy is an integral part of therapeutic treatments for approximately 50% of the patients diagnosed with cancer, yet many countries have inadequate availability of radiotherapy treatment2. Varian is working in collaboration with healthcare providers to change that statistic by creating innovative and integrated solutions to help bring treatment options to those communities who need it most."As part of Siemens Healthineers, Varian is in a unique position to develop cutting-edge products and solutions that bridge the care gap globally," remarked Arthur Kaindl, Head of Varian. "By combining the expertise of the leading imaging and radiotherapy companies, we have the ability to achieve much more than any individual cancer care company by driving connection throughout the entire care continuum."At the ESTRO meeting, Varian will present a range of solutions that will enhance the care continuum, including:HyperSight imaging solution is now available as an optional feature on Ethos, Halcyon, Edge, and TrueBeam radiotherapy platforms. Delivering a revolution in resolution, HyperSight imaging offers superior image quality, enhanced contrast, and faster image acquisition compared to conventional Varian linear-accelerator-based imaging systems.is now available as an optional feature on Ethos, Halcyon, Edge, and TrueBeam radiotherapy platforms. Delivering a revolution in resolution, HyperSight imaging offers superior image quality, enhanced contrast, and faster image acquisition compared to conventional Varian linear-accelerator-based imaging systems

INACTIVE